Central Nervous System (CNS) Cancer Pipeline Review, H2 2012 New Report
Central Nervous System (CNS) Cancer - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Central Nervous System (CNS) Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Central Nervous System (CNS) Cancer.
View full press release